Armistice Capital’s TuHURA Biosciences HURA Stock Holding History

Armistice Capital’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,163	Closed	-$1.75M	–	182
2021 Q3	$1.75M	Buy	+1,163	New	+$3.05M	0.03%	119

Other funds holding HURA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Armistice Capital's HURA Position: Q4 2021 in Review

Armistice Capital sold out of TuHURA Biosciences (HURA) in Q4 2021, closing a stake of 1,163 shares — an estimated $1.75M sold.

Armistice Capital first reported a position in HURA in Q3 2021 and held it in 1 quarter. The position peaked at $1.75M in Q3 2021. 24 funds tracked by Wall St. Rank hold HURA as of Q4 2021.

Armistice Capital reported no remaining TuHURA Biosciences position as of Q4 2021 after selling out during the quarter.
Armistice Capital sold 1,163 TuHURA Biosciences shares in Q4 2021, an estimated $1.75M.
Armistice Capital first reported a position in TuHURA Biosciences in Q3 2021 and held it in 1 quarter.
Armistice Capital's TuHURA Biosciences position peaked at $1.75M in Q3 2021.
24 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2021.

Based on Armistice Capital's 13F filing for Q4 2021, filed 14 Feb 2022.